连续接种流感病毒疫苗与聚肌胞苷酸可保护小鼠抵抗同源和异源病毒攻击
研究在小鼠中比较鼻内接种福尔马林灭活流感病毒疫苗联合聚肌胞苷酸(poly(I:C))连续5天与不联合poly(I:C)的免疫效果。联合poly(I:C)连续5天接种可诱导高水平病毒特异性鼻洗液IgA和血清IgG,并至少维持6个月,且能保护小鼠抵抗同源和异源流感病毒攻击;不联合poly(I:C)接种几乎不诱导应答。
要点
- 鼻内接种灭活流感疫苗联合poly(I:C)连续5天可诱导高水平鼻洗液IgA和血清IgG。
- 不联合poly(I:C)的鼻内接种几乎不诱导病毒特异性抗体应答。
- 联合poly(I:C)连续5天接种的小鼠至少6个月后仍维持高水平鼻洗液IgA和血清IgG。
核心结论
- 连续接种流感病毒疫苗与poly(I:C)是诱导未免疫个体产生初次免疫应答的替代方法。
研究设计与样本
- 在小鼠中比较鼻内接种福尔马林灭活流感病毒疫苗联合或不联合poly(I:C)连续5天的免疫应答及攻毒保护效果。
主要发现
- 鼻内接种福尔马林灭活流感病毒疫苗联合poly(I:C)连续5天可诱导高水平病毒特异性鼻洗液IgA和血清IgG应答,而不联合poly(I:C)接种几乎不诱导应答。
- 联合poly(I:C)连续5天接种的小鼠在接种后至少6个月仍维持高水平病毒特异性鼻洗液IgA和血清IgG。
- 鼻内接种流感病毒疫苗联合poly(I:C)可保护小鼠抵抗同源和异源流感病毒攻击。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mucosal immunity induced through natural infection by influenza virus has potent cross-protective activity, compared to subcutaneous vaccination-induced systemic immunity. Compared to natural infection with influenza virus, however, a single intranasal vaccination with an inactivated influenza virus vaccine and poly(I:C) is not sufficient to induce primary immune response in naïve animals. The reasons for this moderate effect are not fully understood. Here, we demonstrated that intranasal vaccination with formalin-inactivated influenza virus vaccine and poly(I:C) for five consecutive days elicits high levels of virus-specific nasal IgA and serum IgG responses, while vaccination without poly(I:C) induced little response. Mice immunized with influenza virus vaccine and poly(I:C) for five consecutive days sustained high levels of virus-specific IgA in nasal wash and IgG in serum until at least 6months after vaccination. Furthermore, intranasal vaccination with influenza virus vaccine and poly(I:C) protected mice against homologous and heterologous influenza virus challenge. These results suggest that consecutive inoculations of influenza virus vaccine and poly(I:C) is an alternative method to induce primary immune responses in naïve subjects.
引用
- Moriyama M, Chino S, Ichinohe T, et al. Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge. Vaccine. 2017. PMID: 28111142. doi:10.1016/j.vaccine.2017.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。